Seres Therapeutics is a biotherapeutic company that discovers and develops therapeutic products and drugs for the treatment of human diseases, such as infectious, metabolic, and inflammatory diseases. It is owned by Flagship VentureLabs founded by Noubar Afeyan and David Berry.
Timeline
October 2017
Seres Health raises a $2,500,000 grant from Carb-X.
January 2015
Seres Health raises a $65,000,000 series D round from Nestlé Health Science.
December 2014
Seres Health raises a $48,000,000 series C round from Flagship Pioneering.
May 2014
Seres Health raises a $10,000,000 series B round from Alexandria Venture Investments, Enso Ventures, Flagship Pioneering and Mayo Clinic.
November 2013
Seres Health raises a $10,500,000 series A round from Enso Ventures and Flagship Pioneering.
Funding rounds
Patents
People
Name
Role
LinkedIn
Azard Mahamoon
Employee
David Berry
Investor
Eliseo Papa
Employee
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
Is a
CompanyCompany attributes
Pharmaceuticals Industry
Healthcare
BiotechnologyLocation
Cambridge, MassachusettsCompany status
Active
B2X
B2B
Roger Pomerantz
David Berry (inventor)
Noubar AfeyanCrunchbase
Legal name
Seres Health, Inc.
Number of Employees (ranges)
100 – 249
Full address
200 Sidney Street, Cambridge, Massachusetts 02139, US
Carb-X
Flagship Pioneering
Mayo Clinic
Enso Ventures
Alexandria Venture Investments
RA Capital Management
Sofinnova InvestmentsTotal funding amount (USD)
136,000,000
Latest funding round date
October 2017
Latest funding type
Categories
Related Topics
Contributors
- 1
Bridget Smith
I am a Copywriter and Researcher. - 2
Chirag Jain
I am an engineer and a traveler. I love to explore new things around the world and I am on the way of it. I love to take challenges. Thanks! - 3
Rahul Goyal
Researcher - 4
Dushyant Soni
Researcher - 5
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME
